A case report of Kaposiform haemangioendothelioma; response with propranolol and steroids.

Clinical Sarcoma Research Pub Date : 2020-07-30 eCollection Date: 2020-01-01 DOI:10.1186/s13569-020-00134-8
Saurav Verma, Ekta Dhamija, Adarsh Barwad, Venkatesan S Kumar, Sameer Rastogi
{"title":"A case report of Kaposiform haemangioendothelioma; response with propranolol and steroids.","authors":"Saurav Verma,&nbsp;Ekta Dhamija,&nbsp;Adarsh Barwad,&nbsp;Venkatesan S Kumar,&nbsp;Sameer Rastogi","doi":"10.1186/s13569-020-00134-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Kaposiform haemangioendothelioma is a rare vascular tumor and may involve skin, deep soft tissue or bone. It is a locally aggressive tumor usually seen in infants. Here we report a case of kaposiform hemagioendothelioma in a child who responded to propranolol and steroids.</p><p><strong>Case presentation: </strong>A 3-year-old male child presented with a swelling below his right knee with characteristic violet skin lesion. There was no evidence of Kasabach-Merritt phenomenon. After no improvement with several attempts at debridement and anti-tubercular treatment; a diagnosis of Kaposiform Haemangioendothelioma was reached on the basis of overall clinical picture and histology. The child was treated with propranolol and steroids and had an excellent clinical response and a near complete resolution on imaging at 5 months.</p><p><strong>Conclusions: </strong>These cases are often misdiagnosed and despite a delay in diagnosis have good outcomes with appropriate multimodality management. This case highlights the unique and typical characteristics of kaposiform haemangioendothelioma.</p>","PeriodicalId":10684,"journal":{"name":"Clinical Sarcoma Research","volume":"10 ","pages":"12"},"PeriodicalIF":0.0000,"publicationDate":"2020-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s13569-020-00134-8","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Sarcoma Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s13569-020-00134-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Background: Kaposiform haemangioendothelioma is a rare vascular tumor and may involve skin, deep soft tissue or bone. It is a locally aggressive tumor usually seen in infants. Here we report a case of kaposiform hemagioendothelioma in a child who responded to propranolol and steroids.

Case presentation: A 3-year-old male child presented with a swelling below his right knee with characteristic violet skin lesion. There was no evidence of Kasabach-Merritt phenomenon. After no improvement with several attempts at debridement and anti-tubercular treatment; a diagnosis of Kaposiform Haemangioendothelioma was reached on the basis of overall clinical picture and histology. The child was treated with propranolol and steroids and had an excellent clinical response and a near complete resolution on imaging at 5 months.

Conclusions: These cases are often misdiagnosed and despite a delay in diagnosis have good outcomes with appropriate multimodality management. This case highlights the unique and typical characteristics of kaposiform haemangioendothelioma.

Abstract Image

Abstract Image

Abstract Image

卡泊西样血管内皮瘤1例报告服用心得安和类固醇。
背景:卡波西样血管内皮瘤是一种罕见的血管肿瘤,可累及皮肤、深部软组织或骨骼。它是一种局部侵袭性肿瘤,常见于婴儿。在这里,我们报告一个病例卡泊西样血血管内皮瘤在儿童谁响应心得安和类固醇。病例介绍:一名三岁男童,右膝以下肿大,伴特征性紫色皮损。没有证据表明存在卡萨巴赫-梅里特现象。经多次清创和抗结核治疗均无好转;根据整体临床表现和组织学诊断为卡泊西样血管内皮瘤。患儿接受心得安和类固醇治疗,临床反应良好,5个月时影像学几乎完全恢复。结论:这些病例经常误诊,尽管诊断延误,但通过适当的多模式管理,结果良好。本病例突出了卡泊样血管内皮瘤的独特和典型特征。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
期刊介绍: Clinical Sarcoma Research considers for publication articles related to research on sarcomas, including both soft tissue and bone. The journal publishes original articles and review articles on the diagnosis and treatment of sarcomas along with new insights in sarcoma research, which may be of immediate or future interest for diagnosis and treatment. The journal also considers negative results, especially those from studies on new agents, as it is vital for the medical community to learn whether new agents have been proven effective or ineffective within subtypes of sarcomas. The journal also aims to offer a forum for active discussion on topics of major interest for the sarcoma community, which may be related to both research results and methodological topics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信